Table 5:
Age | Alteration | Immunogen | References |
---|---|---|---|
<P0 | ↑ IL-1β and TNF-α mRNA (whole brain) (1) | 500 μg/kg LPS, i.p. on 2 consecutive days | Cai et al., 2000 |
↓ Fas ligand, fractalkine, IL-3, IL-4, IL-5, lympotactin, M-CSF, MIG, MIP-1α, TARC, TECK, TNF-α,VCAM-1 (whole brain) (2) | 20 mg/kg Poly (I:C), i.p. | Ehninger, 2014 | |
↑ TNF-α (whole brain) (3) | 5 mg/kg Poly (I:C), i.v. or 120 μg/kg LPS, i.p. (3 consecutive days) | Arsenault et al., 2014 | |
↑ IlL-6 mRNA (whole brain) (4) | 20 mg/kg Poly (I:C), i.p. | Wu et al., 2015 | |
↑ Il6 mRNA (whole brain) (4); ↑ IL-4, IL-6, IP-10 (whole brain, IL-6+/− offspring, WT mother) (5) | 20 mg/kg Poly (I:C), i.p. | Wu et al., 2017 | |
↑ IL-1β, IL-6, TNF-α, IL-10 mRNA (whole brain) (4) | 50 μg/kg LPS, i.p. | O’Loughlin et al., 2017 | |
P0–7 | ↑ IL-1β (P1); ↓ TNF-α (P7) mRNA (whole brain) (4) | 300 μg/kg LPS, i.p. (2 consecutive days) | Rousset et al., 2006 |
↑ GM-CSF, G-CSF, IL-1β, IL-10,
IL- 12(p70); ↓ IL-2, IL-4, IL-5, IL-10, IL-12(p40) (frontal cortex); ↑ IFNγ, IL-12(p70), IL-17; ↓ IL-2, IL-5, IL-6, IL-10 (cingulate cortex); ↑ IL-6, IL-9; ↓ IL-1β, IL-2, IL-3, IL-4, IL-5, IL-10 (hippocampus) (5) |
20 mg/kg Poly (I:C), i.p. | Garay et al., 2013 | |
↑ FasL, IL-2, IL-3, IL-6; ↓ Eotaxin-2 (cerebellum) (2) | 20 mg/kg Poly (I:C), i.p. | Pendyala et al., 2017 | |
↑ IL-1β mRNA (amygdala) (4) | 50 μg/kg LPS, i.p. | O’Loughlin et al., 2017 | |
↓ GM-CSF, IFNγ, IL-1α, IL-1β, IL-2, IL-5, IL-9, IL-10, IL-13 (frontal cortex); ↓ GM- CSF, IFNγ, IL-1β, IL-10, IL-17 (cingulate cortex); ↑ IL-1α, IL-6; ↓ IL-2, IL-5, IL-9 (hippocampus) (5) | 20 mg/kg Poly (I:C), i.p. | Garay et al., 2013 | |
P8–21 | ↑ MIP-1γ; ↓ ICAM-1, IL-10 (2); ↑ TNF-α (2,3) (cerebellum) | 20 mg/kg Poly (I:C), i.p. | Pendyala et al., 2017 |
↓ G-CSF, GM-CSF, IL-1β, IL-3,
IL-5, IL- 6, IL-10, IL-12(p40), IL-12(P70) (frontal cortex); ↓ G-CSF, IL-1β, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12(p40), IL-12(p70), IL-17 (cingulate cortex); ↓ IL-6 (hippocampus) (5) |
20 mg/kg Poly (I:C), i.p. | Garay et al., 2013 | |
P22–35 | ↑ MIP-1γ; ↓ IFNγ, IL-17 (cerebellum) (2) | 20 mg/kg Poly (I:C), i.p. | Pendyala et al., 2017 |
↑ IL-1α, IL-6, IL-9, IL-10 (frontal cortex); ↑ IFNγ, IL-10 (cingulate cortex) (5) | 20 mg/kg Poly (I:C), i.p. | Garay et al., 2013 | |
>P60 | Increased IL-1β (hippocampus) (6) | 5 mg/kg Poly (I:C), i.v. | Giovanoli et al., 2016b |
Abbreviations: FasL: fas ligand; G-CSF: granulocyte colony-stimulating factor; GM-CSF: granulocyte- macrophage colony-stimulating factor; IFN: interferon; M-CSF: macrophage colony-stimulating factor; MIG: monokine induced by interferon-gamma; MIP: macrophage inflammatory protein; TARC: thymus and activation-regulated chemokine; TECK: thymus expressed chemokine; VCAM: vascular cell adhesion molecule
Superscripts indicate methods used to measure cytokines:
RT-PCR
Cytokine antibody array
Western blot
qRT-PCR
Bead-based multiplex assay
Meso-Scale Discovery V-Plex electrochemiluminescence assay
For the studies in this table, the immunogen was administered via either intraperitoneal (i.p.) or intravenous (i.v.) injection.